Status:
ACTIVE_NOT_RECRUITING
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
Lead Sponsor:
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Collaborating Sponsors:
UnitedHealthcare
Conditions:
HPV Infection
Eligibility:
FEMALE
24-64 years
Phase:
EARLY_PHASE1
Brief Summary
Conducting an early phase clinical trial to assess HPV Antigen Presentation Therapeutic Biological Product Mix activity that suggests the potential for clinical benefit of HPV patients. 1. Treat Infe...
Detailed Description
* Conducting an early phase clinical trial to assess HPV Antigen Presentation Therapeutic Biological Product Mix activity that suggests the potential for clinical benefit of HPV patients * 20 Cervical...
Eligibility Criteria
Inclusion
- Conducting an early phase clinical trial to assess HPV Antigen Presentation Therapeutic Biological Product Mix that suggests the potential for clinical benefit of HPV patients.
- 20 Cervical HPV Infection Patients
- Cervical HPV Infection Patients
- Positive testing HPV by standard PCR assay
- HPV infection without symptoms
- No clinical signs indicative of oncology
- TB negative participant is negative IGRA blood test with TB antigens
Exclusion
- Pregnant
- Thrombosis
- Bleeding
- Allergy
- TB positive participant is positive IGRA blood test with TB antigens
- Symptoms of HPV infection
- Clinical signs suggestive of other infection
- Symptoms suggestive of other infection
- Clinical signs indicative of oncology
- Evidence of critical illness
Key Trial Info
Start Date :
April 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 28 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06959563
Start Date
April 28 2025
End Date
September 28 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine Invention Design, Inc.
Rockville, Maryland, United States, 20853